Pfizer, in a statement Monday, said its Capsugel business had 2010 revenue of $750 million and manufactured more than 180 billion hard capsules during the year, making Capsugel the world leader in hard capsules.
As a result of the deal, Pfizer said it updated its expected 2011 reported revenue range to $65.2 billion to $67.2 billion from $66 billion to $68 billion. The company also said it now expects 2012 revenue of $62.2 billion to $64.7 billion from a previous forecast of $63 billion to $65.2 billion.
-- Written by Joseph Woelfel
>To contact the writer of this article, click here: Joseph Woelfel